Medical Cannabis Solutions
Rhizo Sciences is a Cannabis Consulting, Development and Management company specialising in turnkey solutions for cGMP Manufacturing and international export.
We are based in Seattle, Washington, and bring 8 years of expertise in Medicinal Cannabis cultivation, extraction, manufacturing and distribution.
In 2017 we expanded to consult with clients to help them gain the first licenses in Africa and New Zealand and designed some of the first GMP compliant, INCB/WHO compliant export facilities in Africa and Australasia.
In 2018, the demand for large scale hemp and CBD processing has shifted our USA focus to the hemp industry, where we consult on, design and build facilities capable of processing 1,000+ pounds of hemp biomass into CBD rich hemp extracts per day.
Our turnkey solutions for cannabis cultivation, extraction and product manufacture mean we can rapidly executive new projects in different locations.
We’re leveraging this capability to develop a worldwide network of medicinal cannabis facilities, enabling us export to any legal market worldwide.
Wholesale Medical Cannabis, Hemp and CBD Products
Rhizo Sciences has issued offtake agreements with large scale medical cannabis producers and hemp farmers to supply wholesale medical cannabis, High CBD Hemp flower, Industrial Hemp, and Hemp Biomass to approved purchasers.
We have also contracted industrial scale hemp and cannabis processors to extract hemp and cannabis extracts such as CBD Oil, CBD Distillate and CBD isolate in legal markets. Note that we can only sell cannabis or cannabidiol products to qualified purchasers with proof of funds and necessary licenses and permits.
Medical Cannabis, Hemp and CBD Consulting Services
Rhizo Sciences consults on medical cannabis cultivation, processing, supply chains and product development. We specialise in large scale commercial operations, including go to market strategy and product and brand development.
Learn more about our large scale medical cannabis and hemp-derived CBD solutions, projects and industry outlook.